Evrofarma SA (ATH:EVROF)

Evrofarma Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	49.44	45.72	48.76	45.38	36.7
Revenue Growth (YoY)	8.14%	-6.24%	7.45%	23.66%	8.23%
Cost of Revenue	38.19	36.49	41.7	39.59	32.86
Gross Profit	11.25	9.23	7.06	5.8	3.84
Selling, General & Admin	6.98	6.26	4.64	4.69	4.73
Other Operating Expenses	-0.95	-1.11	-1.24	-1.15	-1.12
Operating Expenses	6.03	5.15	3.4	3.54	3.61
Operating Income	5.22	4.08	3.66	2.26	0.23
Interest Expense	-0.7	-1.19	-1.32	-0.84	-0.78
Earnings From Equity Investments	-	-	0.06	0.02	0.03
Other Non Operating Income (Expenses)	-	0	-0.07	-0.07	-0.01
EBT Excluding Unusual Items	4.53	2.89	2.32	1.36	-0.54
Gain (Loss) on Sale of Investments	-	-	-0	-	-0.02
Gain (Loss) on Sale of Assets	-	-	-	-	0
Asset Writedown	-	-	0.39	0.16	0.3
Pretax Income	4.53	2.89	2.71	1.52	-0.26
Income Tax Expense	1	0.61	0.51	0.1	0.1
Net Income	3.53	2.28	2.2	1.42	-0.36
Net Income to Common	3.53	2.28	2.2	1.42	-0.36
Net Income Growth	54.65%	3.54%	55.18%	-	-
Shares Outstanding (Basic)	14	-	14	14	14
Shares Outstanding (Diluted)	14	-	14	14	14
Shares Change (YoY)	-	-	0.05%	-0.02%	-
EPS (Basic)	0.26	-	0.16	0.10	-0.03
EPS (Diluted)	0.26	-	0.16	0.10	-0.03
EPS Growth	-	-	55.11%	-	-
Free Cash Flow	-0.51	4.13	0.53	0.6	-4.15
Free Cash Flow Per Share	-0.04	-	0.04	0.04	-0.30
Dividend Per Share	-	-	0.050	-	-
Gross Margin	22.76%	20.20%	14.48%	12.77%	10.46%
Operating Margin	10.56%	8.92%	7.50%	4.97%	0.63%
Profit Margin	7.13%	4.99%	4.52%	3.13%	-0.97%
Free Cash Flow Margin	-1.03%	9.03%	1.09%	1.32%	-11.31%
EBITDA	7.17	5.85	5.31	3.75	1.63
EBITDA Margin	14.51%	12.79%	10.89%	8.26%	4.45%
D&A For EBITDA	1.95	1.77	1.66	1.49	1.4
EBIT	5.22	4.08	3.66	2.26	0.23
EBIT Margin	10.56%	8.92%	7.50%	4.97%	0.63%
Effective Tax Rate	22.10%	21.05%	18.66%	6.77%	-
Advertising Expenses	-	-	0.17	0.16	0.12

Source: S&P Global Market Intelligence. Standard template. Financial Sources.